Wei Lu
7 Papers
9 Citations
Wei Lu is an academic researcher. The author has contributed to research in topics: Cirrhosis & Hepatitis B. The author has an hindex of 3, co-authored 3 publications.
Chat about Author
Papers
Blocking and reversing hepatic fibrosis in patients with chronic hepatitis B treated by traditional Chinese medicine (tablets of biejia ruangan or RGT): study protocol for a randomized controlled trial.
Jianhui Qu,Zujiang Yu,Qin Li,Yongping Chen,Dedong Xiang,Lin Tan,Chunliang Lei,Wenlin Bai,Hongyan Li,Qinghua Shang,Liang Chen,Xiaoyu Hu,Wei Lu,Zhiqin Li,Da Chen,Xiaodong Wang,Changjiang Zhang,Guangming Xiao,Xun Qi,Jing Chen,Li Zhou,Guofeng Chen,Yonggang Li,Zhen Zeng,Guanghua Rong,Zheng Dong,Yan Chen,Min Lou,Chunping Wang,Yinying Lu,Cuihong Zhang,Yongping Yang +31 more
TL;DR: The effects of TCM tablets of the compound biejia ruangan (RGT) administered for fibrosis, and entecavir (ETV), on the development of HCC in patients with CHB or hepatitis B virus (HBV)-related compensated cirrhosis in China is evaluated.
33
Synergistic Effect of Biejia-Ruangan on Fibrosis Regression in Patients with Chronic Hepatitis B Treated with Entecavir: A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial.
Guanghua Rong,Yong-Ping Chen,Zujiang Yu,Qin Li,Jingfeng Bi,Lin Tan,Dedong Xiang,Qinghua Shang,Chunliang Lei,Liang Chen,Xiaoyu Hu,Jing Wang,Huabao Liu,Wei Lu,Yan Chen,Zheng Dong,Wenlin Bai,Eric M. Yoshida,Nahum Méndez-Sánchez,Ke-Qin Hu,Xingshun Qi,Yongping Yang +21 more
TL;DR: Adding Biejia-Ruangan to the current standard treatment with NAs in CHB patients with advanced fibrosis or cirrhosis can improve liver fibrosis regression.
31
A Novel Noninvasive Program for Staging Liver Fibrosis in Untreated Patients With Chronic Hepatitis B.
Yan Chen,Yongji Wang,Yong-Ping Chen,Zujiang Yu,Xiaoling Chi,Ke-Qin Hu,Qin Li,Lin Tan,Dedong Xiang,Qinghua Shang,Chunliang Lei,Liang Chen,Xiaoyu Hu,Jing Wang,Huabao Liu,Wei Lu,Weilai Chi,Zheng Dong,Xiao-Dong Wang,Zhiqin Li,Huanming Xiao,Da Chen,Wenlin Bai,Changjiang Zhang,Guangming Xiao,Xun Qi,Jing Chen,Li Zhou,Huiwei Sun,Minghua Deng,Xiaolong Qi,Zheng Zhang,Xingshun Qi,Yongping Yang +33 more
TL;DR: The Chin-CHB score had good diagnostic performance for any stage of liver fibrosis, and was integrated into a novel noninvasive program, named as the Chin- CHB score.
12
Clinical predictors and RT-PCR profile of prolonged viral shedding in patients with SARS-CoV-2 Omicron variant in Shanghai: A retrospective observational study
Wen Zhang,Shuang Zhou,Gang Wang,Min Cao,D.G. Sun,Wei Lu,Lijing Shi,Yongming Luo,Xiang-Tong Xu,Yuting Pu,Caiyu Chen,Hong-qiang Yang,Yuting Sun,Hongyi Hu,Bang-Jiang Fang +14 more
TL;DR: The number of vaccinations and Ct values of ORF 1ab gene were independently associated with a prolonged SARS-CoV-2 RNA shedding.
Effect of birth asphyxia on neonatal blood glucose during the early postnatal life: A multi-center study in Hubei Province, China.
Chun Hua Liu,Hong-yan Liu,Sicong Peng,Shaochuan Pan,Zhisheng Wan,Suying Wu,Chao Fang,Rongguan Jiao,Wen-Xiang Wang,Bin Gan,Shu-JieYang,J. Tan,Xiao-Fang Zhu,Ping-li She,Q. H. Fan,Min Yang,Ji-jian Xie,Jie Sun,Lingyu Zeng,Liangfen Zhang,Yan-Ni Li,Wei Lu,Xian-Tao Yang,Xiong-Fei Xiao,Hong-li Li,Zhengshou Rao,Chuang-jing Gao,Ya Luo,Hong Chen,Ming Yu,Xiaoxu Luan,Yu-Rong Huang,Shi-wen Xia +32 more
TL;DR: The authors in this article found that birth asphyxia is likely to cause neonatal blood glucose disorders, both hypoglycemia and hyperglycemia, during the early postnatal life.
4